XML 29 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Statement of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
SVS Shares (as converted)
Share Capital
Accumulated Other Comprehensive Income
Accumulated Earnings (Deficit)
Non- Controlling Interest
Beginning balance (in shares) at Dec. 31, 2019 261,545,678          
Limited Liability Company (LLC) Members' Equity [Abstract]            
Conversion of Warrants (in shares) 18,354,322          
Ending balance (in shares) at Dec. 31, 2020 279,900,000          
Beginning balance at Dec. 31, 2019 $ 112,028   $ 127,390 $ 0 $ (25,157) $ 9,795
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Purchase of Non-controlling interest (6,900)       (3,950) (2,950)
Deconsolidation of subsidiary 79         79
Derecognition of Non-controlling interest (2,442)         (2,442)
Conversion of Warrants 10,524   10,524      
Distributions to members (47)       (47)  
Net Income (Loss) $ 40,156       38,401 1,755
Issuance of Pubco shares in redemption of membership units (in shares) (279,900,000)          
Beginning balance at Dec. 31, 2020 $ 153,398   137,914 0 9,247 6,237
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
RTO-related issuances, net 652,217   652,217      
Purchase of Non-controlling interest (12,265)   505   (6,975) (5,795)
Issuance of Pubco shares in redemption of membership units (in shares)   279,900,000        
Conversion of Warrants 75,100   75,100      
Reverse takeover ("RTO Financing"), net (in shares)   10,100,000        
Reverse takeover (“RTO Financing”), net 95,420   95,420      
Distributions to minority holders (1,675)         (1,675)
Share-based compensation (in shares)   987,242        
Share-based compensation 48,319   48,319      
Issuance of shares in conjunction with acquisitions (in shares)   29,526,129        
Issuance of shares in conjunction with acquisitions 522,120   522,120      
Warrants issued and exercised (in shares)   3,510,000        
Contingent consideration & other adjustments to purchase accounting (in shares)   289,291        
Contingent consideration & other adjustments to purchase accounting 4,170   4,170      
Net Income (Loss) (54,998)       (57,507) 2,509
Ending balance (in shares) at Dec. 31, 2021   324,312,662        
Ending balance at Dec. 31, 2021 1,481,806   1,535,765 0 (55,235) 1,276
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation (in shares)   3,320,195        
Share-based compensation 43,343   43,343      
Issuance of shares in conjunction with acquisitions (in shares)   7,039,977        
Issuance of shares in conjunction with acquisitions 41,914   41,914      
Noncontrolling interest adjustment for change in ownership (1,567)         (1,567)
Foreign Currency Translation Adjustment (8)     (8)    
Contingent consideration & other adjustments to purchase accounting (in shares)   5,310,540        
Contingent consideration & other adjustments to purchase accounting 44,935   44,935      
Net Income (Loss) (268,873)       (269,164) 291
Ending balance (in shares) at Dec. 31, 2022   339,983,374        
Ending balance at Dec. 31, 2022 $ 1,341,550   $ 1,665,957 $ (8) $ (324,399) $ 0